Dapagliflozin Improves Physical Limitation in HFpEF: PRESERVED-HF

Dapagliflozin Improves Physical Limitation in HFpEF: PRESERVED-HF

The SGLT2 inhibitor dapagliflozin scored a clear win in a randomized, controlled trial with more tha...
read more
Dapagliflozin Effective in Both Women and Men With Heart Failure With Reduced Ejection Fraction

Dapagliflozin Effective in Both Women and Men With Heart Failure With Reduced Ejection Fraction

NEW YORK (Reuters Health) – Unlike some hear...
read more